Visceral fat predominance is associated with erosive esophagitis in Japanese men with metabolic syndrome

European Journal of Gastroenterology and Hepatology

Volumn 24, Issue 8, 2012, Pages 910-916

  Sogabe, Masahiro ^a   Okahisa, Toshiya ^b   Kimura, Yoshitaka ^c   Hibino, Shingo ^d   Yamanoi, Akira ^a  

^a Kagawa Prefectural Cancer Detection Center   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c Department of Gastroenterology   (Japan)

^d Hibino Hospital   (Japan)

Author keywords

erosive esophagitis; metabolic syndrome; subcutaneous fat type metabolic syndrome; ultrasonography; visceral fat type metabolic syndrome

Indexed keywords

ALANINE AMINOTRANSFERASE; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; FATTY LIVER; HIATUS HERNIA; HUMAN; INTRAABDOMINAL FAT; JAPANESE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE;

AGED; ALANINE TRANSAMINASE; BODY MASS INDEX; CHOLESTEROL, LDL; DYSLIPIDEMIAS; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGITIS; HERNIA, HIATAL; HUMANS; INTRA-ABDOMINAL FAT; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREVALENCE; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE;

EID: 84864030679     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328354a354     Document Type: Article

References (48)

1. Miyamoto M, Haruma K, Kuwabara M, Nagano M, Okamoto T, Tanaka M. High incidence of newly developed gastroesophageal reflux disease in the Japanese community: A 6-year follow-up study. J Gastroenterol Hepatol 2008; 23:393-397.
2. Wu JC. Gastroesophageal reflux disease: An Asian perspective. J Gastroenterol Hepatol 2008; 23:1785-1793.
3. Vakil N. Dyspepsia, peptic ulcer, and H. pylori: A remembrance of things past. Am J Gastroenterol 2010; 105:572-574.
4. Sakaguchi M, Oka H, Hashimoto T, Asakuma Y, Takao M, Gon G, et al. Obesity as a risk factor for GERD in Japan. J Gastroenterol 2008; 43:57-62.
5. Breckan RK, Paulssen EJ, Asfeldt AM, Mortensen L, Straume B, Florholmen J. The impact of body mass index and Helicobacter pylori infection on gastro-oesophageal reflux symptoms: A population-based study in Northern Norway. Scand J Gastroenterol 2009; 44:1060-1066.
6. Corley DA, Kubo A. Body mass index and gastroesophageal reflux disease: A systematic review and meta-analysis. Am J Gastroenterol 2006; 101:2619-2628.
7. El-Serag HB, Graham DY, Satia JA, Rabeneck L. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol 2005; 100:1243-1250.
8. Lee SJ, Song CW, Jeen YT, Chun HJ, Lee HS, Um SH, et al. Prevalence of endoscopic reflux esophagitis among Koreans. J Gastroenterol Hepatol 2001; 16:373-376.
9. El-Serag HB, Ergun GA, Pandolfino J, Fitzgerald S, Tran T, Kramer JR. Obesity increased oesophageal acid exposure. Gut 2007; 56:749-755.
10. El-Serag HB, Tran T, Richardson P, Ergun G. Anthropometric correlates of intragastric pressure. Scand J Gastroenterol 2006; 41:887-891.
11. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 2005; 100:190-200.
12. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288:2709-2716.
13. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/ American Heart Association conference on scientific issues related to definition. Circulation 2004; 109:433-438.
14. Watanabe S, Hojo M, Nagahara A. Metabolic syndrome and gastrointestinal diseases. J Gastroenterol 2007; 42:267-274.
15. Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K. Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev 2002; 11:385-391.
16. Bowers K, Albanes D, Limburg P, Pietinen P, Taylor PR, Virtamo J, et al. A prospective study of anthropometric and clinical measurements associated with insulin resistance syndrome and colorectal cancer in male smokers. Am J Epidemiol 2006; 164:652-654.
17. Lee YC, Yen AM, Tai JJ, Chang SH, Lin JT, Chiu HM, et al. The effect of metabolic risk factors on the natural course of gastro-esophageal reflux disease. Gut 2009; 58:174-181.
18. Ierardi E, Rosania R, Zotti M, Principe S, Laonigro G, Giorgio F, et al. Metabolic syndrome and gastro-esophageal reflux: A link towards a growing interest in developed countries. World J Gastrointest Pathophysiol 2010; 15:91-96.
19. Healy LA, Ryan AM, Pidgeon G, Ravi N, Reynolds JV. Lack of differential pattern in central adiposity and metabolic syndrome in Barrett's esophagus and gastroesophageal reflux disease. Dis Esophagus 2010; 23:386-391.
20. Park JH, Park DI, Kim HJ, Cho YK, Sohn CI, Jeon WK, et al. Metabolic syndrome is associated with erosive esophagitis. World J Gastroenterol 2008; 14:5442-5447.
21. The Examination Committee of Criteria for Metabolic Syndrome. The definition and criteria of metabolic syndrome. J Jpn Soc Intern Med 2005; 94:794-809.
22. Suzuki R, Watanabe S, Hirai Y, Akiyama K, Nishide T, Matsushima Y, et al. Abdominal wall fat index, estimated by ultrasonography, for assessment of the ratio of visceral fat to subcutaneous fat in the abdomen. Am Med 1993; 95:309-314.
23. Kawamoto R, Ohtsuka N, Nakamura S, Ninomiya D, Inoue A. Preperitoneal fat thickness by ultrasonography and obesity-related disorders. J Med Ultrason 2007; 34:93-99.
24. Hirooka M, Kumagi T, Kurose K, Nakanishi S, Michitaka K, Matsuura B, et al. A technique for the measurement of visceral fat by ultrasonography: Comparison of measurements by ultrasonography and computed tomography. Intern Med 2005; 44:794-799.
25. Lonardo A, Bellini M, Tartoni P, Tondelli E. The bright liver syndrome: Prevalence and determinants of a bright liver echopattern. Int J Gastroenterol Hepatol Res 1997; 29:351-356.
26. Nilsson M, Lundegardh G, Carling L, Ye W, Lagegren J. Body mass and reflux oesophagitis: An oestrogen-dependent association? Scand J Gastroenterol 2002; 37:626-630.
27. Lagergren J, Bergstrom R, Nyren O. No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study. Gut 2000; 47:26-29.
28. Corley DA, Kubo A, Zhao W. Abdominal obesity, ethnicity and gastrooesophageal reflux symptoms. Gut 2007; 56:756-762.
29. Gunji T, Sato H, Iijima K, Fujibayashi K, Okumura M, Sasabe N, et al. Risk factors for erosive esophagitis: A cross-sectional study of a large number of Japanese males. J Gastroenterol 2011; 46:448-455.
30. Bergman RN, Kim SP, Hsu IR, Catalano KJ, Chiu JD, Kabir M, et al. Abdominal obesity: Role in the pathophysiology of metabolic disease and cardiovascular risk. Am J Med 2007; 120:S3-S8.
31. De Vries DR, van Herwaarden MA, Smout AJ, Samsom M. Gastroesophageal pressure gradients in gastroesophageal reflux disease: Relations with hiatal hernia, body mass index, and esophageal acid exposure. Am J Gastroenterol 2008; 103:1349-1354.
32. Pandolfino JE, El-Serag HB, Zhang Q, Shah N, Ghosh SK, Kahrilas PJ. Obesity: A challenge to esophagogastric junction integrity. Gastroenterology 2006; 130:639-649.
33. Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007; 56:1010-1013.
34. Beasley LE, Koster A, Newman AB, Javaid MK, Ferrucci L, Kritchevsky SB, et al. Inflammation and race and gender differences in computerized tomography-measured adipose depots. Obesity 2009; 17:1062-1069.
35. Chung SJ, Kim D, Park MJ, Kim YS, Kim JS, Jung HC, et al. Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: A crosssectional case-control study of 7078 Koreans undergoing health check-ups. Gut 2008; 57:1360-1365.
36. Nam SY, Choi IJ, Ryu KH, Park BJ, Kim HB, Nam B-H. Abdominal visceral adipose tissue volume is associated with increased risk of erosive esophagitis in men and women. Gastroenterology 2010; 139:1902-1911.
37. Kato M,Watabe K, Hamasaki T, Umeda M, Furubayashi A, Kinoshita K, et al. Association of low serum adiponectin levels with erosive esophagitis in men: An analysis of 2405 subjects undergoing physical check-ups. J Gastroenterol 2011; 46:1361-1367.
38. Sogabe M, Okahisa T, Hibino S, Yamanoi A. Usefulness of differentiating metabolic syndrome into visceral fat type and subcutaneous fat type using ultrasonography in Japanese males. J Gastroenterol 2011; 47:293-299.
39. Meining A, Classen M. The role of diet and lifestyle measures in the pathogenesis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 2000; 95:2692-2697.
40. Suganami T, Tanimoto-Koyama K, Nishida J, Itoh M, Yuan X, Mizuarai S, et al. Role of the toll-like receptor 4/NF-kappaB pathway in saturated fatty acidinduced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 2007; 27:84-91.
41. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007; 117:175-184.
42. Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications. Hepatology 2010; 51:679-689.
43. Nakamura T, Shirakawa K, Masuyama H, Sugaya H, Hiraishi H, Terano A. Minimal change oesophagitis: A disease with characteristic differences to erosive oesophagitis. Aliment Pharmacol Ther 2005; 21:19-26.
44. Fujiwara Y, Arakawa T. Epidemiology and clinical characteristics of GERD in the Japanese population. J Gastroenterol 2009; 44:518-534.
45. Dent J. Gastro-oesophageal reflux disease. Digestion 1998; 59:433-445.
46. Labenz J, Blum AL, Bayerdö rffer E, Meining A, Stolte M, Bö rsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997; 112:1442-1447.
47. Rajendra S, Ackroyd R, Robertson IK, Ho JJ, Karim N, Kutty KM. Helicobacter pylori, ethnicity and the gastro-oesophageal reflux disease spectrum: A study from the East. Helicobacter 2007; 12:177-183
48. Shahabi S, Rasmi Y, Jazani NH, Hassan ZM. Protective effect of H. pylori against gastroesophageal reflux disease may be due to neuroimmunological anti-inflammatory mechanism. Immunol Cell Biol 2008; 86:175-178.